Committees

1. To improve public awareness of BSGCT and gene and cell therapy.
2. To provide a forum, in the form of public engagement days, for students, patients, affected families and other members of the public to become better informed about the reality, complexities and issues surrounding gene and cell therapy and its therapeutic application.
3. To educate and inspire the next generation to become scientists, with particular focus on gene transfer and stem cell technology.

Members
Christos Georgiadis (Chair)
Linda Popplewell
Alan Parker
Mustafa Munye
Robyn Bell
Nora Clarke
Aniekan Etuk

Public Engagement

1. To build a UK wide network of gene and cell therapy researchers and promote the field among early career scientists.
2. To promote engagement of early career researchers in gene and cell therapy events.
3. To highlight career development opportunities for early career researchers.
4. To facilitate collaborations between gene and cell therapy researchers

Members
Robyn Bell (co-Chair)
Lisa McArthur (co-Chair)
Carly Bliss (co-Chair)
Tushar Choudary
David K. Cole
Christos Georgiadis
Tasha Oppermans
Alan L. Parker

Early Career Development & Collaboration

1. To keep abreast of current regulation in the UK and beyond for gene and cell therapies
2. To facilitate information dissemination to BSGCT membership
3. To liaise with other societies when required regarding clinical matters
4. To act as advisors, upon request, from agencies that control regulation and routes to clinic.

Members
Sian Harding (Chair)
Emma Morris (Vice-Chair)
Claire Booth
Uta Griesenbach
Andy Baker
Chris Denning
Rafael Yanez

Clinical Translation & Regulatory Affairs

1. To edit and maintain BSGCT Blogs, BSGCT webpage and BSGCT social media pages
2. To engage members and non-members with the society
3. To ensure latest/breaking news relevant to the field is posted in a timely fashion and keep posted information relevant
4. To highlight and promote upcoming events, Blogs and other society news

Members
Ralph Hector (Chair)
Mustafa Munye
Sian Stafford

Communication & Promotion

News

Switching Up T Cell Therapies

With the huge effort that’s currently being spent developing more resistant T cell therapies with new targets and increased efficacy against solid tumours, it’s easy to overlook the toxicity concerns and the innovative ways scientists are tackling them.

Could It Be A One-Stop Solution For The Most Common Cause Of Irreversible Blindness?

Vered Smith is our 2020 Science Writing Competition winner with her article about glaucoma.

Rebuilding the brain with stem cells: is it a no-brainer?

Anitta Rose Chacko is our 2020 Science Writing Competition runner-up with her article about Parkinson's disease.

The Churchillian dilemma of Gene Editing

Felicity Crawshay-Williams is our 2020 Science Writing Competition runner-up with her article about the genetic code.

Skin; Lets Break It Down

Christopher Smith receives a special mention for our 2020 Science Writing Competition with his poem about the SGPL1 gene.

Programmed to kill: Synthetic virology to attack cancer

Carefully modified viruses are becoming major new drugs in the battle against cancer.

Gene-loaded sutures to promote tendon healing

Injuries to tendons, the tissue that links muscle to bone, are commonly seen in the clinic yet few strategies exist to improve upon slow and largely poor tendon healing standards.

3D Printing of Personalized Cardiac Patches and Hearts

Tissue engineering for cardiac repair has reached an advanced stage and engineered constructs are starting to be approved for first-in-human trials.

Retirement of Prof George Dickson, a founder of British Society for Gene and Cell Therapy

The British Society for Gene Therapy, as BSGCT was originally named, was founded seventeen years ago by a number of pioneers in the field including Prof George Dickson.

The origin of your noggin

‘Where do you get your brains from?!’

Human Germline Editing – What’s the big deal?

In November 2018, He Jiankui, gave a presentation at the second international summit on Human Genome Editing.

One image at a time: using cryoEM to unpick how viruses infect cells

Over the last few years a wave of virus-based therapies has progressed through late stage clinical evaluation and to (or near to) the market place.

A final chance to breathe: Could gene therapy cure cystic fibrosis lung disease?

For decades, scientists and doctors have worked tirelessly towards developing effective treatments for CF.

Cracking the enthesis code

More than three quarters of shoulder repair surgeries fail while long-term disabilities occurring as a direct consequence of sports-related injuries, such as pain and osteoporosis, remain a huge burden (Apostolakos et al, 2014).

Overcoming the disconnection

We all have a universe inside our head. A hundred billion neurons making connections with one another, constantly firing and passing messages from our brain, down the spinal cord, and to every part of our body.

Putting the dopamine back in Parkinson’s

One in 37 people in the UK are diagnosed with Parkinson’s disease (PD) during their lifetime (Parkinson’s UK, 2018).

Rare is not so rare

In the disease surfactant protein B deficiency, a certain protein called surfactant protein B is missing in the lung of new-born babies.

CRISPR-engineered T cells in patients with refractory cancer

A recent paper from Carl June’s lab published in the journal Science¹ described results of a University of Pennsylvania clinical trial that administered in three patients T-cells engineered to target cancer cells using a virus whilst simultaneously engineered using CRISPR to stop expression of 3 genes.

Precision correction of pathogenic mutations using prime editing technology

A broad range of genome editing tools are currently available enabling targeted scission at a predetermined DNA locus.